Group revenue at footwear brand Dr Martens jumped by 20% to £348.6m in the full year to 31 March 2018, driven by a particularly strong performance across Europe, the Middle East and Africa.  EBITDA rose by 33% year on year to £50m and like-for-like retail revenue was up by 7%. Direct-to-consumer revenue was up by 26% to £140.7m and retail revenue was up 23% to £43.6m Ecommerce grew by 35% to £43.6m and wholesale revenue was up by 16% to £207.9m.

Paul Mason, chairman of Dr Martens, said: “This has been a fantastic year for Dr Martens. We’ve delivered another set of strong results with broad-based growth across all regions and channels and double-digit revenue and EBITDA performances. This, in the context of the wider macro-economic uncertainty that exists in a few of our key markets, is testament to both the strength of our brand, our heritage, and consumer proposition, and the execution of our strategy. There is still significant scope for growth across our markets, particularly via our direct-to-consumer channels, and this will remain a strategic priority in the years ahead. We will continue to focus on our four strategic pillars of focusing on our product, consumer centricity, balanced global growth and operational efficiency. “